Tocagen's Series D - II Round

Tocagen raised a round of funding on October 05, 2010.

Tocagen is a clinical-stage biopharmaceutical company pursuing the discovery, development, and commercialization of products for the treatment of cancer. Tocagen is initially focusing on treatments fo…

Articles about Tocagen's Series D - II Round: